CIBC Private Wealth Group
PCVX icon

CIBC Private Wealth Group’s Vaxcyte PCVX Stock Holding History

CIBC Private Wealth Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$358K Buy
7,756
+6,400
+472% +$286K ﹤0.01% 970
2025
Q3 		$48.8K Buy
1,356
+1,350
+22,500% +$44.7K ﹤0.01% 1811
2025
Q2 		$195 Buy
+6
New +$197 ﹤0.01% 2918

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CIBC Private Wealth Group's PCVX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Vaxcyte (PCVX) stake by 472% in Q4 2025, buying an estimated $286K and bringing the position to 7,756 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #970.

CIBC Private Wealth Group first reported a position in PCVX in Q2 2025 and has held it in 3 quarters since. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

  • CIBC Private Wealth Group held 7,756 shares of Vaxcyte worth $358K as of Q4 2025.
  • CIBC Private Wealth Group bought 6,400 Vaxcyte shares in Q4 2025, an estimated $286K.
  • Vaxcyte made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #970 holding.
  • CIBC Private Wealth Group first reported a position in Vaxcyte in Q2 2025 and has held it in 3 quarters since.
  • 295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.